Top Brand Choice
Simbrinza Opthalmic 1%/0.2%
SIMBRINZA® (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% combines two proven medications into a single treatment. The first (brinzolamide) decreases the production of the clear fluid inside your eye. The second (brimonidine) also decreases fluid production while increasing fluid outflow. Together, they can reduce high pressure in the eye.1 Take SIMBRINZA® Suspension as your doctor prescribes: the recommended dose is one drop in the affected eye(s) 3 times a day. If you are already using another type of eyedrop they should be taken at least 5 minutes apart.1
brinzolamide/brimonidine tartrate ophthalmic suspension
The recommended dose is one drop of SIMBRINZA® Suspension in the affected eye(s) three times daily. Shake well before use. SIMBRINZA® Suspension may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart.
The most commonly reported side effects include blurred vision, eye irritation, bad taste, dry mouth, and eye allergy.1 SIMBRINZA® Suspension is contraindicated in patients who are hypersensitive to any component of this product and neonates and infants under the age of 2 years.
Product Code: 13205
What is a Generic Drug?
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.